These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91. Increased host ATP efflux and its conversion to extracellular adenosine is crucial for establishing Basu M; Gupta P; Dutta A; Jana K; Ukil A J Cell Sci; 2020 Apr; 133(7):. PubMed ID: 32079656 [TBL] [Abstract][Full Text] [Related]
92. Genetic analysis of an allergic rhinitis cohort reveals an intercellular epistasis between FAM134B and CD39. Melchiotti R; Puan KJ; Andiappan AK; Poh TY; Starke M; Zhuang L; Petsch K; Lai TS; Chew FT; Larbi A; Wang de Y; Poidinger M; Rotzschke O BMC Med Genet; 2014 Jun; 15():73. PubMed ID: 24970562 [TBL] [Abstract][Full Text] [Related]
93. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions. Yoshida N; Shigemori K; Donaldson N; Trevisani C; Cordero NA; Stevenson KE; Bu X; Arakawa F; Takeuchi M; Ohshima K; Yoda A; Ng SY; Weinstock DM Blood; 2020 Apr; 135(17):1467-1471. PubMed ID: 31961925 [TBL] [Abstract][Full Text] [Related]
94. Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models. Zhang H; Feng L; de Andrade Mello P; Mao C; Near R; Csizmadia E; Chan LL; Enjyoji K; Gao W; Zhao H; Robson SC J Clin Invest; 2022 Jul; 132(13):. PubMed ID: 35775486 [TBL] [Abstract][Full Text] [Related]
95. Hippocampal CD39/ENTPD1 promotes mouse depression-like behavior through hydrolyzing extracellular ATP. Cui QQ; Hu ZL; Hu YL; Chen X; Wang J; Mao L; Lu XJ; Ni M; Chen JG; Wang F EMBO Rep; 2020 Apr; 21(4):e47857. PubMed ID: 32133764 [TBL] [Abstract][Full Text] [Related]
96. PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+γδ Treg polarization. Zhan Y; Zheng L; Liu J; Hu D; Wang J; Liu K; Guo J; Zhang T; Kong D JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34283812 [TBL] [Abstract][Full Text] [Related]
97. Clinicopathological features of adult T-cell leukemia/lymphoma with T-follicular helper phenotype. Muto R; Miyoshi H; Nakashima K; Takeuchi M; Hamasaki M; Ohshima K Cancer Med; 2024 Mar; 13(6):e7050. PubMed ID: 38506241 [TBL] [Abstract][Full Text] [Related]
98. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Takenaka MC; Gabriely G; Rothhammer V; Mascanfroni ID; Wheeler MA; Chao CC; Gutiérrez-Vázquez C; Kenison J; Tjon EC; Barroso A; Vandeventer T; de Lima KA; Rothweiler S; Mayo L; Ghannam S; Zandee S; Healy L; Sherr D; Farez MF; Prat A; Antel J; Reardon DA; Zhang H; Robson SC; Getz G; Weiner HL; Quintana FJ Nat Neurosci; 2019 May; 22(5):729-740. PubMed ID: 30962630 [TBL] [Abstract][Full Text] [Related]
99. Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis. Picozza M; Cristofoletti C; Bresin A; Fioretti M; Sambucci M; Scala E; Monopoli A; Cantonetti M; Pilla MA; Accetturi MP; Borsellino G; D'Atri S; Caprini E; Russo G; Narducci MG J Invest Dermatol; 2022 Nov; 142(11):3009-3019.e9. PubMed ID: 35533722 [TBL] [Abstract][Full Text] [Related]
100. Cancer CD39 drives metabolic adaption and mal-differentiation of CD4 Wang Y; Liu M; Zhang L; Liu X; Ji H; Wang Y; Gui J; Yue Y; Wen Z Cell Death Dis; 2023 Dec; 14(12):804. PubMed ID: 38062068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]